$CVS

CVS Health Corp

  • NEW YORK STOCK EXCHANGE INC.
  • Retail Trade
  • Drugstore Chains
  • Pharmacies and Drug Stores

PRICE

$73.4 โ–ฒ0.191%

Extented Hours

VOLUME

6,062,071

DAY RANGE

72.13 - 73.555

52 WEEK

72.11 - 105.89

Join Discuss about CVS with like-minded investors

profile
@dros #droscrew
recently

$GOOG Mar 110.75 C $GOOGL Mar31 105 C $CHPT Mar 15 C $FUBO Feb 2.5 C $SBUX Feb 112 C $AAPL Feb 150 C $CVS Feb 92 C $PTON Apr 25 C $VOD Apr 12 C $OSTK Mar 20 C $UMC Jan-24 7.5 C $CNHI Jun 17.5 C

96 Replies 6 ๐Ÿ‘ 9 ๐Ÿ”ฅ

profile
@dros #droscrew
recently

$GOOG Mar 110.75 C $GOOGL Mar31 105 C $CHPT Mar 15 C $FUBO Feb 2.5 C $SBUX Feb 112 C $AAPL Feb 150 C $CVS Feb 92 C $PTON Apr 25 C $VOD Apr 12 C $OSTK Mar 20 C $UMC Jan-24 7.5 C $CNHI Jun 17.5 C

75 Replies 15 ๐Ÿ‘ 11 ๐Ÿ”ฅ

profile
@dros #droscrew
recently

cvs is sort of crazy man > @lucullus said: for $10.6 bill. ๐Ÿ˜ฑ

105 Replies 6 ๐Ÿ‘ 15 ๐Ÿ”ฅ

profile
@licinius #droscrew
recently

https://www.cvshealth.com/news/company-news/cvs-health-to-acquire-oak-street-health.html

131 Replies 8 ๐Ÿ‘ 10 ๐Ÿ”ฅ

profile
@licinius #droscrew
recently

$CVS confirm $osh acquistion agreement

141 Replies 8 ๐Ÿ‘ 10 ๐Ÿ”ฅ

profile
@Renato_Decarolis #decarolis
recently

_"(Il Sole 24 Ore Radiocor Plus) - New York, 08 feb - Apertura in calo a Wall Street. Ieri, seduta volatile e chiusura in rialzo, dopo le parole del presidente della Federal Reserve, Jerome Powell, all'Economic Club di Washington. 'Ci vorra' un periodo lungo, e tortuoso, per riportare l'inflazione verso l'obiettivo del 2'%, ha detto Powell, ma il processo disinflazionistico, come dichiarato dopo l'ultima riunione, 'e' iniziato'. Per Powell, ci sara' 'un significativo calo dell'inflazione nel 2023' e, secondo lui, 'servira' il 2024 per portare l'inflazione vicina al 2%'. L'attenzione degli investitori torna sulle trimestrali, con Chipotle che perde quasi il 5% in avvio dopo conti inferiori alle attese, mentre CVS e Uber guadagnano rispettivamente il 2,5% e il 6,5% dopo una trimestrale migliore delle attese. Positivo anche l'avvio di Fox News, che guadagna il 6,5% dopo ricavi in rialzo del 4% grazie alla trasmissione della Coppa del Mondo e del football americano. Dopo i primi minuti di scambi, il Dow Jones perde 88,23 punti (-0,26%), lo S&P 500 cede 18,39 punti (-0,44%), il Nasdaq e' in ribasso di 54,92 punti (-0,45%). Il petrolio Wti al Nymex sale dell'1,43% a 78,24 dollari al barile."_

48 Replies 15 ๐Ÿ‘ 10 ๐Ÿ”ฅ

profile
@licinius #droscrew
recently

ummm today will be interesting. Nothing official on $OSH , RUMOURED $10.5 BILL deal. If it happens $CVS will be buying a company with about 80% of the revenue of $cano and about 25-30% more debt.

126 Replies 10 ๐Ÿ‘ 10 ๐Ÿ”ฅ

profile
@Navneet #droscrew
recently

$osh 29 calls did come before close > @Pal said: @lucullus $CANO moving AH on $OSH/$CVS news

92 Replies 10 ๐Ÿ‘ 13 ๐Ÿ”ฅ

profile
@Pal #droscrew
recently

@lucullus $CANO moving AH on $OSH/$CVS news

83 Replies 14 ๐Ÿ‘ 9 ๐Ÿ”ฅ

profile
@dros #droscrew
recently

https://www.wsj.com/articles/cvs-walmart-to-cut-pharmacy-hours-as-staffing-squeeze-continues-11674796388

100 Replies 14 ๐Ÿ‘ 9 ๐Ÿ”ฅ

profile
@dros #droscrew
recently

https://www.wsj.com/articles/cvs-walmart-to-cut-pharmacy-hours-as-staffing-squeeze-continues-11674796388

81 Replies 8 ๐Ÿ‘ 6 ๐Ÿ”ฅ

profile
@dros #droscrew
recently

$SQ Jan27 90 C $NIO Mar 12.5 C $IGT Mar 26 C $PARA Feb10 21.5 C $CZR Feb03 50 C $LU Feb 3 C $FTCH Jan27 6.5 C $TXN Mar 190 C $ROKU Feb03 57 C $MSFT Jan27 260/265 C S $ONON Jul 25 C $ATVI Jun 95 C $TXN Mar 190 C $LILAK Apr 10 C $TEVA Jan024 12 C $EWY Feb 69 C $CVS Mar 95 C $OKE Mar 75 C $ARKK Jan27 40 C

47 Replies 8 ๐Ÿ‘ 7 ๐Ÿ”ฅ

profile
@dros #droscrew
recently

$SQ Jan27 90 C $NIO Mar 12.5 C $IGT Mar 26 C $PARA Feb10 21.5 C $CZR Feb03 50 C $LU Feb 3 C $FTCH Jan27 6.5 C $TXN Mar 190 C $ROKU Feb03 57 C $MSFT Jan27 260/265 C S $ONON Jul 25 C $ATVI Jun 95 C $TXN Mar 190 C $LILAK Apr 10 C $TEVA Jan024 12 C $EWY Feb 69 C $CVS Mar 95 C $OKE Mar 75 C $ARKK Jan27 40 C

64 Replies 15 ๐Ÿ‘ 11 ๐Ÿ”ฅ

profile
@licinius #droscrew
recently

yep @dros $CVS was interested before in the fall, but it all fell thru for some reason, $CANO has been obliterated since. So either they found out some deadly secret in $CANo or the management were to greedy...or the Right of First refusal to $Humana got in the way

79 Replies 6 ๐Ÿ‘ 15 ๐Ÿ”ฅ

profile
@licinius #droscrew
recently

$OSH halted after hrs I think,$CVS buying at $27. I would think significant implications for $CANO stock price

104 Replies 12 ๐Ÿ‘ 8 ๐Ÿ”ฅ

profile
@licinius #droscrew
recently

however these stocks are in big demand Humana,CVS, Amazon etc looking for acquistions, so who knows. Insiders own 24% and they have average buys at 8-11. miles above here

87 Replies 15 ๐Ÿ‘ 15 ๐Ÿ”ฅ

profile
@licinius #droscrew
recently

Summary Cano Health currently presents an interesting investment opportunity with a potential short-term 58% upside. Recently, rumors appeared that Cano Health has received acquisition interest, with healthcare industry giants CVS Health, Humana and UnitedHealth among the rumored buyers. Given ongoing pressure from two prominent activists and industry consolidation trends, I expect a company sale to be announced shortly. Looking for more investing ideas like this one? Get them exclusively at Special Situation Investing. Learn More ยป Health visitor and a senior woman during nursing home visit A Potential company sale might be brewing up behind the scenes. Cano Health (NYSE:CANO) owns and operates senior primary care health centers in nine US states, with a primary focus on Florida. Recently, Bloomberg, Reuters and WSJ reported that the company has received acquisition interests, with health industry giants Humana (HUM), UnitedHealth (UNH) and CVS Health (CVS) mentioned as the front-runners to buyout CANO. Acquisition rumors follow activism from several of CANO's shareholders. In March, Daniel Loeb's Third Point (2.2% of voting power) started to push the company towards strategic alternatives, arguing that CANO should address the value gap (arising from the company going public through a SPAC) by initiating a company sale. Then, in August, Owl Creek Asset Management (owns 1%) delivered a letter, also considering the company undervalued versus peers and industry transactions. As it stands, it seems that the management/insiders (who own 55%) have been under pressure from two prominent activists to sell the company. Not surprisingly, in August, CANO's management stated that the company is open to all strategic alternatives and has hired financial advisors. Reportedly, the second round of discussions is currently ongoing, with the deal possibly finalized in the upcoming weeks. Reports do not mention the acquisition price, however, peer/transaction multiples (also mentioned by the activist Owl Creek) suggest $14/share might be a reasonable price tag - this would imply a 58% upside from current levels. Buyout rumors come amid broader healthcare industry consolidation trends as large healthcare insurers are scooping up healthcare providers in an effort to combine insurance and healthcare provider activities. The industry is currently in a shift towards value based care - a model where providers are paid based on patient health outcomes (as opposed to the traditional fee-for-service model where patients pay for each service rather than outcome). Naturally, the value-based care model closely aligns the interests of both health insurance firms and healthcare providers. Numerous industry executives, including Humana's Medicare President, have noted that value-based model has benefits for providers/insurers, including noticeably higher contribution margins, thus pushing up incentives for consolidation. Not surprisingly, these dynamics have spurred a number of acquisitions of healthcare providers by major health insurers. CVS is currently buying health care platform provider Signify Health (Sep'22), UNH is scooping up home care provider LHC Group (announced in Mar'22) and HUM has already acquired home healthcare provider Kindred at Home (Aug'21). The industry has also seen increasing M&A activity from non-insurers entering the space, including Amazon (AMZN) acquiring primary care company One Medical (announced in Jul'22, by the way CVS was one of the bidders there as well) and Walgreens Boots Alliance (WBA) purchasing a majority stake in primary care provider VillageMD (Oct'21). These dynamics and the fact that CANO might be an attractive target have also been recently reiterated by CANO's CEO: I expect continued consolidation and acceleration in the paradigm shift of value-based care. And what this means for us is yet another validation of how attractive our asset is and the industry as a whole. A Potential acquisition would make strategic sense for either of the rumored buyers HUM, UNH or CVS given CANO's extensive presence in Florida's primary care market. CANO is reportedly the largest independent value-based primary care provider to Medicare/Medicaid patients in the state. Meanwhile, three potential suitors currently rank as the three largest primary care insurers in the Florida. Humana and Cano have seemingly deep ties - HUM has been invested in Cano Health prior to CANO's IPO and still owns an undisclosed stake. Currently, CANO is HUM's biggest independent primary care provider in Florida. Interestingly, as part of their earlier agreement, HUM has a right of first refusal, meaning that HUM can match any acquisition offer made for CANO. Notably, HUM has significantly expanded its investment in primary senior care in the last five years, recently stating that the TAM is very large at $700bn. As part of its joint venture with PE firm Welsh Carson, Humana now aims to open 100 new CenterWell senior primary care clinics in the next three years. From the CEO's remarks during Q2'22 earnings call: We do see some great opportunity today, both CenterWell primary care and the home are agnostic and continue to see great growth, serving both other payers and other parts of the Medicare system. And at the same time, we're also seeing opportunity within our primary - within our pharmacy area to offer some agnostic opportunities there. So the ability for it to integrate and also to expand beyond the Medicare side of the business is really at the heart of what you see us more formally creating the CenterWell service side, while on the insurance side, continuing to leverage the efficiencies across the various different insurance platforms. Meanwhile, CVS's management, in addition to the recent acquisition of Signify Health, has recently stated that their priority is the same - to expand into the primary care segment: From Morgan Stanley Healthcare Conf: Well I think we are urging, obviously - we're very urging, I just ask our teams and I think if you think about our strategy, really we've been very clear that we want to extend into care delivery and we're starting with Signify. We can't always determine the order. Obviously primary care is something we believe we need to advance because we really want to enable consumers to have a differentiate experience and improve health outcomes. So we're playing our game. From the CVS Q2'22 earnings call: As you would expect, we are being very disciplined both strategically and financially, as we pursue kind of our M&A strategy. We can't be in the primary care without M&A. We've been very clear about that. Valuation Chart Comp Filings At current price levels, CANO seems undervalued on a TTM/2022E revenue basis relative to larger peers OSH (also owns and operates primary care centers) and AGL (runs primary care physician networks so not as comparable). Moreover, recently announced ONEM and SGFY acquisitions were done at noticeably higher multiples. Activist Owl Creek notes the following reasons for why CANO might be trading at a discount to peers/industry transactions: Unfortunately, Cano has consistently traded at a discount to its peers due to its SPAC heritage, its hybrid model (owned and operated medical centers along with affiliates), and heavy concentration in the South Florida market. One could argue for some discount due to one or more of these factors, but the valuation discrepancy between Cano and peers is highly punitive. Another activist Third Point also agrees that the undervaluation is explained by both SPAC heritage and the company's shareholder base (given dual class structure and high insider ownership): However given recent developments at the Issuer and taking into account the market's largely unfavorable view of companies taken public through special purpose acquisition vehicles, the Reporting Persons believe the Board of Directors should immediately engage financial and legal advisors to commence a review of strategic alternatives. [โ€ฆ] The Reporting Persons believe this strategic review should focus on a sale of the Issuer, and that a properly run sales process is likely to result in offers representing a substantial premium to the Issuer's trading price. The Reporting Persons believe that the Issuer is unlikely to achieve such valuation on a stand-alone basis, in part due to structural issues with its shareholder base. The activist Owl Creek has stated that CANO has been undervalued by the market despite having higher 2022E revenues than both OSH/AGL and being on track to exceed 2022 membership/revenue/EBITDA guidance. Using a 3x revenue multiple based on peers OSH/AGL and Amazon's acquisition of ONEM, Owl Creek arrives at an acquisition price tag of $14/share. The markets have moved down a bit since the letter was written, so a 3x multiple would now translate to a $13/share price. More background on CANO Historical financials are provided below: Table Company Filings Financially, since going public in 2020, CANO has managed to record high revenue growth - 93% in 2021. Notably, the growth has to a large degree been driven by acquisitions, including purchase of University Health Care and Doctor's Medical Center for a total of $900m (announced in Jun'21 and Jul'21). This has allowed the company to significantly increase its patient base as number of memberships has expanded from 156k to 282k over the last year. That said, the business is yet to turn profitable and is still burning cash - $135m in 2021 operating losses. From a liquidity perspective, the company is quite highly levered with $878m in net debt (compared to $4.2bn market cap). Given CANO's business model, the company needs extensive capital to accelerate further growth. At current share price levels, any equity raise would seem highly dilutive given that even after the buyout rumors the stock trades below pre-2022 levels of $9-$16/share. CANO's shares are rather tightly held with 55% of the voting power (Class A + Class B shares) held by the management + insiders. CANO went public in 2020 through a SPAC backed by Starwood Capital CEO Barry Sternlicht who now holds 9% voting power. Another 33% of total shares are owned by a PE firm InTandem Capital Partners which has backed the company since 2016. Both Sternlicht and InTandem's managing partner Elliot Cooperstone currently sit on CANO's board. Interestingly, Cooperstone was previously the CEO of Prodigy Health Group which was acquired by Aetna, a subsidiary of CVS Health. Another 17% are held by six institutional investors, including FMR (7%), BlackRock (3%) and Millennium Asset Management (2%), among others. Risks According to the activist Owl Creek, last year CVS stated that the company had well over $10bn to deploy towards strategic initiatives related to value-based care. With the SGFY acquisition, the company will spend around $7bn, potentially implying that the management might not be willing to pursue another large acquisition. This risk, however, seems limited given CVS's overall large gross cash position ($15bn in cash + investments) and the fact that SGFY captures a slightly different market niche than CANO - it is a healthcare platform which does not own and operate health centers. Management/insiders not agreeing to sell their stake. That said, considering prominent activist pressure, current market turbulence and the fact that the company is yet to inflect towards profitability, an offer at $14/share - a share price close to 2021 highs - could seal the deal. Conclusion CANO presents a very interesting investment opportunity with a short potential timeline. I believe that prominent activist involvement and industry consolidation dynamics point to a company sale brewing up behind the scenes. Importantly, risk/reward seems to be highly favorable here, suggesting that investors might consider CANO as a long position in their portfolios.

70 Replies 11 ๐Ÿ‘ 9 ๐Ÿ”ฅ

profile
@dros #droscrew
recently

$CVS did not confirm spec it walked away from $CANO deal

92 Replies 9 ๐Ÿ‘ 9 ๐Ÿ”ฅ

profile
@dros #droscrew
recently

$CVS reportedly no longer pursuing $CANO deal

62 Replies 7 ๐Ÿ‘ 8 ๐Ÿ”ฅ

profile
@dros #droscrew
recently

$PBR Oct14 15.5 C $TWTR Nov04 53/54 C Spd $CANO Oct 9 C $TWTR Oct 53 C $CANO Nov 10 C $CVS Nov 92.5 C $OVV Oct 60 C $WYNN Oct 75 C $SPB Jan 50 C $LPI Oct 85 C $TWTR Oct28 50 C $C Jan-24 55 C $SHOP Apr 25 C

77 Replies 8 ๐Ÿ‘ 10 ๐Ÿ”ฅ

profile
@dros #droscrew
recently

RECAP 10/7 Unusual Calls: $PBR Oct14 15.5 C $TWTR Nov04 53/54 C Spd $CANO Oct 9 C $TWTR Oct 53 C $CANO Nov 10 C $CVS Nov 92.5 C $OVV Oct 60 C $WYNN Oct 75 C $SPB Jan 50 C $LPI Oct 85 C $TWTR Oct28 50 C $C Jan-24 55 C $SHOP Apr 25 C

127 Replies 13 ๐Ÿ‘ 10 ๐Ÿ”ฅ

profile
@NoobBot #Crypto4Noobs
recently

**pkedrosky:** ADHD Drug Adderall Runs Low at CVS, Walgreens as Demand Soars https://t.co/iO7ihttWK3 https://twitter.com/pkedrosky/status/1572037583055753223

48 Replies 12 ๐Ÿ‘ 7 ๐Ÿ”ฅ

TR
@trademaster #TradeHouses
recently

By Bansari Mayur Kamdar and Devik Jain (Reuters) -Wall Street's main indexes were set for a dour start to the week as investors worried about hawkish signals from U.S. Federal Reserve policymakers in the face of slowing economic growth. A four-week summer rally for the Nasdaq and the S&P 500 snapped last week as megacap growth companies slumped on Friday, with the benchmark 10-year Treasury yield hitting nearly 3% on inflation fears. [US/] High-growth and technology companies such as Apple Inc (NASDAQ:AAPL) and Tesla (NASDAQ:TSLA) Inc fell 1.6% and 1.8%, respectively, in trading before the bell on Monday. Lenders JPMorgan Chase & Co (NYSE:JPM) and Bank of America (NYSE:BAC) fell more than 1% each amid a broader risk-off mood. Banking giants collectively face more than $1 billion in regulatory fines for employees' use of unapproved messaging tools, including email and apps such as WhatsApp. The CBOE Volatility index, Wall Street's fear gauge, rose to 23.16, its highest level in over two weeks. After a rough start to the year, the benchmark S&P 500 recovered nearly 16% from its mid-June lows helped by strong earnings and hopes of a dovish pivot by the Fed. Focus this week is on Fed Chair Jerome Powell's speech at a central banking conference in Jackson Hole on Friday for further cues on the central bank's monetary policy tightening path. "The market convinced itself that the CPI last month suggested peak inflation has been reached ... but that was short sighted," said Kenny Polcari, managing partner at Kace Capital Advisors. "Jackson Hole will give Powell an opportunity to reset the narrative and suggest the Fed is going to remain vigilant and aggressive." According to economists polled by Reuters, the Fed will raise rates by 50 basis points in September. Traders are also expecting a slightly higher chance of a 50 bps hike over a third 75 bps hike, even as several Fed policymakers have pushed back against expectations of a dovish pivot and emphasized the fight against inflation is ongoing. Investors will also be looking for details on the central bank's plans to reduce its nearly $9 trillion balance sheet, a process that started in June. The Fed's favored inflation gauge, the PCE price index, will also be released this week. With recession fears lingering and investors eager for any clues about the economy's strength, other U.S. data will be closely awaited this week, including flash PMIs, the second estimate of second quarter GDP and University of Michigan consumer sentiment. Economic slowdown fears have hit markets globally, with China's central bank trimming some key lending rates on Monday in a bid to support a slowing economy and a stressed housing sector. At 8:32 a.m. ET, Dow e-minis were down 323 points, or 0.96%, S&P 500 e-minis were down 48.5 points, or 1.15%, and Nasdaq 100 e-minis were down 194 points, or 1.46%. Signify Health Inc jumped 40.2% following a report on Sunday that UnitedHealth Group Inc (NYSE:UNH), Amazon.com Inc (NASDAQ:AMZN), CVS Health Corp (NYSE:CVS) and Option Care Health (NASDAQ:OPCH) Inc are bidding to acquire the company. AMC Entertainment (NYSE:AMC) Holdings Inc tumbled 37.7% after UK-based rival Cineworld Group, the world's second-largest cinema operator, warned of a possible bankruptcy filing.

128 Replies 8 ๐Ÿ‘ 7 ๐Ÿ”ฅ

profile
@Marcosx #ivtrades
recently

$CVS nice base has #s soon though

56 Replies 7 ๐Ÿ‘ 8 ๐Ÿ”ฅ

profile
@dros #droscrew
recently

RECAP 7/1 Unusual Puts: $STWD Aug 19 P LAZR Jul08 6.5 P $AVYA Jan 1.5 P $FFIE Jan 5 P $CVS Jul08 88 P

132 Replies 6 ๐Ÿ‘ 9 ๐Ÿ”ฅ

profile
@dros #droscrew
recently

*CVS, WALMART LIMIT PLAN B PILLS AFTER SURGE IN DEMAND: DJ

55 Replies 13 ๐Ÿ‘ 7 ๐Ÿ”ฅ

ST
@stevengo #StockTraders.NET
recently

FB LTHM COUP AMD TTD ZIM RBLX JPM PM Short NET COIN UPST DASH DIS CVS NVAX

101 Replies 13 ๐Ÿ‘ 13 ๐Ÿ”ฅ

profile
@NoobBot #Crypto4Noobs
recently

**@TheCryptoDog:** Just got the call -CVS upped our initial expectations, putting @trybetterbrand in 5800 stores this Fall, all of their "core locations."We'll be available across the whole USA. The CVS big stamp gives us a lot of leverage, too. Steadily becoming a brand name. https://twitter.com/TheCryptoDog/status/1525409100145733632

125 Replies 14 ๐Ÿ‘ 12 ๐Ÿ”ฅ

ST
@stevengo #StockTraders.NET
recently

$AMD, $QCOM, $CVS and added to positions from yesterday.

66 Replies 7 ๐Ÿ‘ 12 ๐Ÿ”ฅ

ST
@stevengo #StockTraders.NET
recently

CPI numbers helped with the adds > @stevengo said: Started some shorts today, but the market is extended, so giving it room to add on daily levels if there is a bounce. $HD, $MRNA, $CVS, $MP, $USB. Room at add on all positions.

69 Replies 10 ๐Ÿ‘ 15 ๐Ÿ”ฅ

ST
@stevengo #StockTraders.NET
recently

MRK VLO XEL OXY Short CVS QCOM AMD ZIM PG MU PM EBAY MU COIN

149 Replies 13 ๐Ÿ‘ 12 ๐Ÿ”ฅ

ST
@stevengo #StockTraders.NET
recently

Started some shorts today, but the market is extended, so giving it room to add on daily levels if there is a bounce. $HD, $MRNA, $CVS, $MP, $USB. Room at add on all positions.

40 Replies 12 ๐Ÿ‘ 6 ๐Ÿ”ฅ

profile
@Marcosx #ivtrades
recently

$CVS trade well on a beat

131 Replies 9 ๐Ÿ‘ 8 ๐Ÿ”ฅ

profile
@AJAJ #droscrew
recently

CVS COST having a field day today

99 Replies 12 ๐Ÿ‘ 8 ๐Ÿ”ฅ

ST
@stevengo #StockTraders.NET
recently

Liking longs today! Will try a short on $QCOM, but only a starter due to a bounce today > @stevengo said: MSFT MRK WMT EOG NKE Short ON CVS ABBV WFC FB QCOM ZIM MRVL

97 Replies 6 ๐Ÿ‘ 9 ๐Ÿ”ฅ

ST
@stevengo #StockTraders.NET
recently

MSFT MRK WMT EOG NKE Short ON CVS ABBV WFC FB QCOM ZIM MRVL

113 Replies 10 ๐Ÿ‘ 6 ๐Ÿ”ฅ

ST
@stevengo #StockTraders.NET
recently

OXY MSFT MRNA CF EOG AA COP Short VERU TSLA SQ ZM ON CVS XPEX

115 Replies 13 ๐Ÿ‘ 12 ๐Ÿ”ฅ

profile
@AJAJ #droscrew
recently

I'm loyal to CVS :)

43 Replies 6 ๐Ÿ‘ 8 ๐Ÿ”ฅ

ST
@stevengo #StockTraders.NET
recently

PG PEP FIS CVS HPQ MSFT Short GE GM SNOW MRNA SQ PDD JD

58 Replies 6 ๐Ÿ‘ 13 ๐Ÿ”ฅ

profile
@AJAJ #droscrew
recently

I am loyal to CVS

122 Replies 14 ๐Ÿ‘ 10 ๐Ÿ”ฅ

profile
@AJAJ #droscrew
recently

look at that close on CVS .. perfect 100

68 Replies 13 ๐Ÿ‘ 14 ๐Ÿ”ฅ

profile
@NoobBot #Crypto4Noobs
recently

**@CNBC:** Florida reaches $878 million opioid settlements with CVS, Teva, others https://t.co/P9XFoh82fq https://twitter.com/CNBC/status/1509197132804276232

71 Replies 8 ๐Ÿ‘ 14 ๐Ÿ”ฅ

profile
@Benlax #droscrew
recently

cvs very active today

48 Replies 12 ๐Ÿ‘ 8 ๐Ÿ”ฅ

ST
@stevengo #StockTraders.NET
recently

$XOM good long with range to recycle shares into yesterday high and reload. > @stevengo said: ABBV JNJ XOM CVS SLB MRK Short CRM NFLX DDOG

103 Replies 14 ๐Ÿ‘ 9 ๐Ÿ”ฅ

ST
@stevengo #StockTraders.NET
recently

ABBV JNJ XOM CVS SLB MRK Short CRM NFLX DDOG

128 Replies 6 ๐Ÿ‘ 14 ๐Ÿ”ฅ

ST
@stevengo #StockTraders.NET
recently

Watchlist for tomorrow: COST BBY MDT UNH CVS Short HD LOW

141 Replies 11 ๐Ÿ‘ 8 ๐Ÿ”ฅ

profile
@NoobBot #Crypto4Noobs
recently

CVS Eyes Metaverse With 4 NFT-Related Trademarks https://www.coindesk.com/business/2022/03/04/cvs-eyes-metaverse-with-4-nft-related-trademarks/?utm_medium=referral&utm_source=rss&utm_campaign=headlines

82 Replies 9 ๐Ÿ‘ 7 ๐Ÿ”ฅ

profile
@dros #droscrew
recently

Upgrades 2/14: $ALL $ASND $BE $BXSL $CMA $DFS $GT $MU $OSCR $ST $TGI $TREX $TU $WSO $ZION . Downgrades 2/14: $AGNC $CRNC $CVS $G $IAA $JPM $NLY $PGR $PRQR $TSN $TXN $USB $ZEN

84 Replies 15 ๐Ÿ‘ 9 ๐Ÿ”ฅ

profile
@CarlosH-carvan #ivtrades
recently

$CVS raised to $120

116 Replies 15 ๐Ÿ‘ 10 ๐Ÿ”ฅ

Key Metrics

Market Cap

94.07 B

Beta

0.59

Avg. Volume

8.71 M

Shares Outstanding

1.28 B

Yield

3.05%

Public Float

0

Next Earnings Date

2023-05-03

Next Dividend Date

2023-04-20

Company Information

CVS Health is a different kind of health care company. It is a diversified health services company with nearly 300,000 employees united around a common purpose of helping people on their path to better health. In an increasingly connected and digital world, it is meeting people wherever they are and changing health care to meet their needs. Built on a foundation of unmatched community presence, its diversified model engages one in three Americans each year. From its innovative new services at HealthHUB locations, to transformative programs that help manage chronic conditions, it is making health care more accessible, more affordable and simply better.

CEO: Larry Merlo

Website:

HQ: 1 Cvs Dr Woonsocket, 02895-6146 Rhode Island

Related News